The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Head Office Relocation,Research Facility Expansion

19 Jul 2013 07:00

RNS Number : 6779J
Plant Health Care PLC
19 July 2013
 



19 July 2013

 

PLANT HEALTH CARE PLC

 

Plant Health Care relocates head office and expands research facilities

 

Plant Health Care (AIM/CISX: PHC.L), a leading provider of naturally derived products to the agriculture industry, announces that it is relocating its headquarters from Pittsburgh, PA to Raleigh, NC. The relocation will take place during the remainder of 2013, with completion of the transition by the end of this year. 

 

The company is also significantly increasing its research activities and personnel. The research facilities have now moved from their previous location to a much-expanded office and laboratory facility in the Seattle, WA area. The new facilities are approximately four times the size of the previous location and will accommodate additional senior scientists and technicians.

 

Dr. Christopher Richards, Chairman of Plant Health Care commented on the head office relocation: "The Board and Shareholders of Plant Health Care concluded that relocating the headquarters of the company to one of the major global agriculture industry communities was in the best interests of the company. North Carolina is home to a number of leading agriculture players and offers world-class infrastructure, workforce and resources for our business."

 

Paul Schmidt, CEO of Plant Health Care commented on the research expansion: "Our recent successful placing enables us to ramp-up our research activities significantly over the next few years. The primary focus of this enhanced effort will be the continued discovery and development of the Harpin technology platform, driven by the current commercial success of Harpin alpha-beta and by very promising early results with third generation products."

 

Dr. Zhongmin Wei, Vice President and Chief Science Officer of Plant Health Care commented: "The expansion of the research investment and activities is an exciting development for Plant Health Care. We have developed a remarkable platform of technology and intellectual property and the opportunity to continue expanding and accelerating this development is extremely exciting. I have been involved in the development of Plant Health Care's technology for a long time and am thrilled with the opportunity to take this platform to the next level."

 

- ENDS-

 

About Plant Health Care, plc: Plant Health Care, plc ("PHC") is a leading provider of naturally derived products for plants and soil. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management.

 

Further information is available at: www.planthealthcare.com or please contact:

 

 

Plant Health Care plc
 
Paul Schmidt, Chief Executive Officer
Tel: +1-412-826-5488
Stephen Weaver, Finance Director
Tel: +1-412-826-5488
 
 
Nomura Code Securities
 Tel: +44 (0) 20 7776 1200
Clare Terlouw / Chris Golden
 
 
 
Powerscourt
Tel: +44 (0) 20 7250 1446
Paul Durman / Nick Dibden / Sophie Moate
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGMNGRVGFZZ
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.